FindTrial
Sign In

A Study to Determine the Frequency and Risk Factors on the Formation of New Antibodies Against Red Cell Antigen Following Transfusion.

A Study on the Prevalence of Red Cell Alloimmunisation and Stratification of Associated Risk Factor at a Tertiary Care Centre - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/061412
Enrollment
20000
Registered
2024-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R768- Other specified abnormal immunological findings in serum

Interventions

Intervention1: NIL: NIL

Sponsors

MAHE MANIPAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Recipients of blood transfusion for the requests received In the Department of Immunohematology and blood transfusion within Kasturba Hospital, Manipal

Exclusion criteria

Exclusion criteria: Recipients of red cell transfusion from outside hospitals other than KH, Manipal

Design outcomes

Primary

MeasureTime frame
1)the prevalence of red cell alloimmunization in the recipient’s blood before transfusion. 2)identify the risk factors associated with red cell alloimmunization & in turn develop strategies to prevent alloimmunization.Timepoint: Assessment will be at the Baseline.—

Secondary

MeasureTime frame
identify the risk factors associated with red cell alloimmunization & in turn develop strategies to prevent alloimmunization.Timepoint: Assessment will be at the Baseline.—

Countries

India

Contacts

Public ContactDr. KARTIK IYER

KMC MAHE MANIPAL

chenna.deepika@manipal.edu9901470899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026